14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
ECG vs RAL: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 17, 2026, Everus Construction Group, Inc. (ECG) is the stronger overall head-to-head candidate over Ralliant Corporation (RAL) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). ECG carries a Unified Composite Score of 50.8/100 (HOLD) at $84.73 (11.7x Forward P/E, 8.2% operating margin), whereas RAL carries 35.6/100 (SELL) at $67.14 (18.6x Forward P/E, 15.0% operating margin).
Technical & Structure Timing Caution: ECG is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 40.1); meanwhile RAL trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 46.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ECG vs RAL. Trailing 12-month operating profitability (ECG 8.2% vs RAL 15.0%) and valuation multiples (ECG 11.7x vs RAL 18.6x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Engineering & Construction value chain with $4.4B market capitalization and 8.2% operating margin.
OpEx & R&D Reinvestment5.4% of Rev ($252M)
90D Engineering Disclosures0 Published
RAL Moat ProfileScale & Operating Efficiency Moat
Electronic Components Operator
Competes within the Electronic Components value chain with $7.6B market capitalization and 15.0% operating margin.
OpEx & R&D Reinvestment36.6% of Rev ($833M)
90D Engineering Disclosures0 Published
Investor FAQ ECG vs RAL Key Questions & Quantitative Answers
As of Nov 17, 2026, Everus Construction Group, Inc. (ECG) is the stronger overall head-to-head candidate over Ralliant Corporation (RAL) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). ECG carries a Unified Composite Score of 50.8/100 (HOLD) at $84.73 (11.7x Forward P/E, 8.2% operating margin), whereas RAL carries 35.6/100 (SELL) at $67.14 (18.6x Forward P/E, 15.0% operating margin). Technical & Structure Timing Caution: ECG is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 40.1); meanwhile RAL trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 46.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
ECG leads the Growth & Scale pillar: ECG posts +40.3% YoY revenue growth and +61.3% YoY earnings growth on $4.66B TTM revenue (13.6% gross margin, 8.2% operating margin), compared with RAL at +17.2% YoY revenue growth and +120.0% YoY earnings growth on $2.28B TTM revenue (51.6% gross margin, 15.0% operating margin). On trailing 12-month operating scale, ECG generates $4.66B in USD-normalized revenue versus $2.28B for RAL. In operating R&D and SG&A reinvestment, ECG deploys 5.4% of Rev ($252M) (0 90-day corporate R&D disclosures) versus 36.6% of Rev ($833M) (0 disclosures) for RAL.
ECG screens cheaper on headline valuation multiples. ECG trades at 11.7x Forward P/E, 15.1x Trailing P/E, N/M PEG, and 1.0x EV/Revenue (5.1% FCF margin), whereas RAL trades at 18.6x Forward P/E, 21.3x Trailing P/E, N/M PEG, and 3.3x EV/Revenue (20.2% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ECG (40.3% ROE) versus RAL (-51.8% ROE) capital efficiency.
In options market volatility and institutional positioning, ECG carries 93.7% implied volatility (12th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (2.16β · 127% Vol realized risk). By comparison, RAL carries 41.7% implied volatility (58th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.60β · 67% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.